sr 140333 has been researched along with sr141716 in 2 studies
Studies (sr 140333) | Trials (sr 140333) | Recent Studies (post-2010) (sr 140333) | Studies (sr141716) | Trials (sr141716) | Recent Studies (post-2010) (sr141716) |
---|---|---|---|---|---|
236 | 0 | 12 | 2,229 | 60 | 631 |
Protein | Taxonomy | sr 140333 (IC50) | sr141716 (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0069 | |
Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.0081 | |
Cannabinoid receptor 1 | Homo sapiens (human) | 0.0219 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.0069 | |
Cannabinoid receptor 2 | Homo sapiens (human) | 2.4666 | |
Cannabinoid receptor 1 | Mus musculus (house mouse) | 0.025 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.108 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.795 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borrelli, F; Capasso, F; Izzo, AA; Mascolo, N | 1 |
Bianchetti, A; Croci, T; Di Marzo, V; Di Palo, S; Ferla, G; Guagnini, F; Matias, I; Mukenge, S; Valenti, M | 1 |
2 other study(ies) available for sr 140333 and sr141716
Article | Year |
---|---|
Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors.
Topics: Animals; Atropine; Benzamides; Benzoxazines; Body Fluids; Cannabinoids; Defecation; Dose-Response Relationship, Drug; Gastrointestinal Motility; Hexamethonium Compounds; Intestines; Male; Mice; Morpholines; Muscarinic Agonists; Naphthalenes; Neurokinin-1 Receptor Antagonists; Piperidines; Pyrazoles; Quinuclidines; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, Muscarinic; Receptors, Neurokinin-2; Rimonabant | 1999 |
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Modulators; Case-Control Studies; Colon; Diverticulum; Endocannabinoids; Female; Glycerides; Humans; Imidazoles; Isoproterenol; Male; Middle Aged; Morpholines; Muscle Contraction; Muscle, Smooth; Naphthalenes; Neurokinin-1 Receptor Antagonists; Piperidines; Polyunsaturated Alkamides; Propanolamines; Pyrazoles; Quinuclidines; Rimonabant; Substance P; Tetrodotoxin | 2006 |